Second External Advisory Board Meeting

On 30 June 2025, the project convened the second meeting of its External Advisory Board (EAB). The meeting’s primary focus was to provide a comprehensive update on the project’s progress over the past year, highlighting key developments, challenges overcome, and the current status.

The session brought together esteemed EAB members, including Jean-Charles Flores, Managing Director of Anthos-ID, and Andreas Falk, CEO of BioNanoNet Forschungsgesellschaft mbH, who actively contributed to the discussions.

Project Coordinator Ilker Dogan opened the meeting by thanking the EAB members for their continued support. He highlighted their important role in helping the project move in the right direction and shared the main achievements reached by month 12. He presented the consortium’s progress by month 12, including key milestones achieved and strengthened collaboration among project partners. The EAB members contributed valuable recommendations to further enhance the project’s development.

The meeting concluded on a positive note, with the project team thanking the EAB members for their valuable input. Their feedback will help guide the next steps as the project continues to move forward.